Home > Riviste > Minerva Pneumologica > Fascicoli precedenti > Minerva Pneumologica 2019 March;58(1) > Minerva Pneumologica 2019 March;58(1):27-35

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW   

Minerva Pneumologica 2019 March;58(1):27-35

DOI: 10.23736/S0026-4954.19.01840-6

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Early noninvasive ventilation treatment for respiratory failure due to severe community-acquired pneumonia

Antonello NICOLINI 1 , Lara PISANI 2, Catia CILLÓNIZ 3, 4, 5, Gianluca FERRAIOLI 6

1 Unit of Respiratory Diseases, Hospital of Sestri Levante, Sestri Levante, Genoa, Italy; 2 Unit of Respiratory and Critical Care, Department of Cardiac-Thoracic and Vascular Diseases, University Hospital St. Orsola-Malpighi, Bologna, Italy; 3 Department of Pneumology, Clinical Institute of Thorax, Hospital Clinic of Barcelona, Barcelona, Spain; 4 Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; 5 Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain; 6 Emergency Department, Tigullio Hospital, Lavagna, Genoa, Italy



INTRODUCTION: Acute respiratory failure (ARF) frequently complicates severe community-acquired pneumonia (CAP) that together with sepsis increases patient mortality. The background of the noninvasive ventilation (NIV) use is to overcome an episode of ARF avoiding invasive mechanical ventilation (IMV) and its associated morbidity.
EVIDENCE ACQUISITION: We performed a systematic review of the available English literature published up to December 2018 inclusive and focused on ARF in adult CAP population. Database searches identified 177 articles; of these, only 16 were retained for data extraction.
EVIDENCE SYNTHESIS: After analyzing all data, we observed that uncertainties in the current literature do not allow firm and definitive recommendations concerning the early use of NIV in hypoxemic CAP patients. IMV still remains a standard of care for many cases of severe CAP.
CONCLUSIONS: Nonetheless, NIV is part of our armamentarium and some optimally selected patients clearly benefit from its use. However, in this setting NIV can be considered a valid and useful strategy in some well-selected patients.


KEY WORDS: Respiratory insufficiency - Pneumonia - Noninvasive ventilation

inizio pagina